What is the difference between a biosimilar and a generic drug?
Biosimilar drugs are often confused with generic drugs. Another key difference is that generics are copies of synthetic drugs, while biosimilars are modeled after drugs that use living organisms as important ingredients.
What makes a drug a biosimilar?
A biosimilar drug has a structure that is highly similar to, but not exactly the same, as a brand name biologic drug. A biosimilar behaves in much the same way so that there are “no meaningful differences” between it and its brand name biologic.
What is an example of a biosimilar?
An example of an approved biosimilar is Amjevita (adalimumab-atto), the first biosimilar approved for the blockbuster Humira (adalimumab) used to treat rheumatoid arthritis and psoriasis, among many other uses.
What drugs have biosimilars?
FDA-Approved Biosimilar Products
| Biosimilar Name | Approval Date | Reference Product |
|---|---|---|
| Riabni (rituximab-arrx) | December 2020 | Rituxan (rituximab) |
| Hulio (adalimumab-fkjp) | July 2020 | Humira (adalimumab) |
| Nyvepria (pegfilgrastim-apgf) | June 2020 | Neulasta (pegfilgrastim) |
| Avsola (infliximab-axxq) | December 2019 | Remicade (infliximab) |
Why are biosimilars different?
As biologic medicines, biosimilars are inherently different from generics due to their molecular size and structure, and the complexity and cost of their development. Biosimilars also have significantly higher research and development costs and risks and are more complex to manufacture than small-molecule generics.
What is the difference between a biosimilar and a biologic?
A biosimilar is a biologic that is highly similar to, and has no clinically meaningful differences from, another biologic that’s already FDA-approved (referred to as the reference product or original biologic). This means biosimilars: Are given the same way (same route of administration).
What do biosimilars treat?
Biosimilars are safe and effective medications for treating many illnesses such as chronic skin and bowel diseases (like psoriasis, irritable bowel syndrome, Crohn’s disease and colitis), arthritis, kidney conditions, and cancer.
Is Humira a biosimilar?
AbbVie’s blockbuster drug Humira has more competition coming—the first FDA-approved biosimilar that may be substituted for the monoclonal antibody at the pharmacy.
Are biosimilar drugs safe?
Yes, biosimilars are absolutely safe. Every drug that’s been approved for your use by the FDA must meet very high standards of safety. This includes all biosimilars and biologics. They are prescription drugs, so in the U.S., the FDA regulates how they are manufactured and delivered to you.
How many biosimilar drugs are there?
The number of biosimilars currently approved by the FDA is thirty-one. The most recent biosimilar approval was Byooviz (ranibizumab-nuna) on September 17, 2021.
What diseases do biosimilars treat?
How are biosimilars different?
What is the difference between a biosimilar and a generic?
A Generic is a chemically derived medicinal product, usually a simple, homogeneous small molecule, whose bioequivalence must be demonstrated. However, a Biosimilar is a medicinal product of biological origin, usually with a complex structure, and large proteins (such as antibodies) that are subject of heterogeneity.
How do biosimilars differ from generics?
Lanton: Biosimilars are completely different from generics. First off, generics are chemically-based. They’re used a lot for maintenance medications and sometimes to cure but mostly for maintenance medications. They use small molecules, which is different from biosimilars.
What are biosimilar medications?
Biosimilars drugs—sometimes referred to as biogenerics—are highly similar versions of biologic medicines made from living microorganisms found in plant or animal cells. Biosimilar pharmaceuticals are drugs that have the same active properties as other licensed drugs.
What are biosimilar medicines?
Biological and biosimilar medicines include: certain hormones for hormone deficiencies (e.g. insulin for diabetes and growth hormone for growth hormone disorders) monoclonal antibodies to treat autoimmune diseases and cancers blood products (e.g. to treat haemophilia) medicines for regulating the immune system (e.g. to treat multiple sclerosis) enzymes (e.g. vaccines to prevent a number of diseases.
